Where can I buy Erdafitinib in China?

Erdafitinib (Erdafitinib) is a new generation of oral anti-cancer drugs that is a tyrosine kinase inhibitor. Its main function is to inhibit the fibroblast growth factor receptor (FGFR) and interfere with the abnormally activated FGFR signaling pathway, thereby inhibiting the growth and spread of cancer cells.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.

FGFRis a type of receptor closely related to processes such as cell growth, differentiation, and angiogenesis. In some cancers, the FGFR gene often undergoes abnormal activation or mutation, leading to the occurrence and development of tumors. The uniqueness of erdafitinib lies in its specificity and ability to precisely intervene in this signaling pathway, providing a targeted treatment for specific types of cancer.

Currently, the main application area of erdafitinib is the treatment of advanced or metastatic urothelial cancer, especially those patients with abnormal activation of theFGFR gene. Clinical trials showed that erdafitinib showed significant efficacy in this patient group, so it was approved by the US FDA in 2019 and became one of the innovative drugs for the treatment of this type of bladder cancer.

However, like many anti-cancer drugs, erdafitinib may also cause some adverse reactions, including but not limited to hypertension, fatigue, hand-foot syndrome, etc. When using erdafitinib, patients need to undergo regular examinations under the supervision of a professional doctor to ensure the efficacy of the drug and the patient's overall health.